World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 18 January 2021
Main ID:  NCT01278290
Date of registration: 14/01/2011
Prospective Registration: No
Primary sponsor: Hospital de Niños R. Gutierrez de Buenos Aires
Public title: Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Scientific title: Triptorelin Acetate Utilization for the Early Diagnosis of Central Precocious Puberty (CPP) in Girls.
Date of first enrolment: December 2009
Target sample size: 46
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01278290
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  Phase 3
Countries of recruitment
Argentina
Contacts
Name:     Maria G Ropelato, PhD
Address: 
Telephone:
Email:
Affiliation:  División de Endocrinología, Hospital de Niños Ricardo Gutierrez, Buenos Aires, Argentina
Name:     Analía V Freire, MD
Address: 
Telephone:
Email:
Affiliation:  División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina
Key inclusion & exclusion criteria

Inclusion Criteria:

- premature thelarche and/or

- accelerated growth velocity (above 90 percentile)

- advanced bone age at least 1.5 year in relation to chronological age.

Exclusion Criteria:

- contact with sources of exogenous estrogens in the last four months previous to
evaluation,

- suspicion of peripheral precocious puberty,

- previous central nervous system illness or suspicion of organic central precocious
puberty.



Age minimum: 3 Years
Age maximum: 8 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Central Precocious Puberty
Sexual Precocity
Intervention(s)
Diagnostic Test: Triptorelin acetate and Gonadorelin acetate
Diagnostic Test: Gonadorelin acetate and Triptorelin acetate
Primary Outcome(s)
Estradiol [Time Frame: 24 hs]
LH [Time Frame: 3 hs]
Secondary Outcome(s)
FSH [Time Frame: 3 hs]
Secondary ID(s)
HNinosBuenosAires-Triptorelin
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history